Drug abuse

Amphetamines

Tamara Phillips, Emily C. Eastwood, John H. Harkness

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Amphetamine and amphetamine analogues, such as methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA), have been used for many reasons. Amphetamine has well-known stimulant properties and was once commonly prescribed for treatment of depression and obesity (Anglin et al., 2000). Amphetamine-like drugs and psychostimulants such as methylphenidate and modainil are currently sometimes prescribed for treatment of attention-deicit hyperactivity disorder (ADHD) and narcolepsy, and may be “self-prescribed” as cognitive enhancers (Fredriksen et al., 2013; Hirai and Nishino, 2011; Steiner and Van Waes, 2013). However, amphetamines have profound abuse potential and a high risk for neurotoxicity with chronic use and dependency. More signiicant problems with addiction tomethamphetamine are currently seen and the clinical pharmacology has been nicely reviewed (Cruickshank and Dyer, 2009). However, a recent paper compared the efects of intranasal d-amphetamine and methamphetamine on mood, performance, and physiological efects in humans and concluded that the drugs have similar dose-related proiles of efects and may therefore have equivalent abuse potential (Kirkpatrick et al., 2012a).

Original languageEnglish (US)
Title of host publicationBehavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders
PublisherCambridge University Press
Pages330-349
Number of pages20
ISBN (Print)9781107360556, 9781107044456
DOIs
StatePublished - Jan 1 2014

Fingerprint

amphetamines
amphetamine
Amphetamines
drug abuse
Amphetamine
Substance-Related Disorders
Methamphetamine
Nootropic Agents
N-Methyl-3,4-methylenedioxyamphetamine
Narcolepsy
Dextroamphetamine
Methylphenidate
Clinical Pharmacology
drugs
neurotoxicity
Pharmaceutical Preparations
pharmacology
emotions
Obesity
Depression

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)

Cite this

Phillips, T., Eastwood, E. C., & Harkness, J. H. (2014). Drug abuse: Amphetamines. In Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders (pp. 330-349). Cambridge University Press. https://doi.org/10.1007/CBO9781107360556

Drug abuse : Amphetamines. / Phillips, Tamara; Eastwood, Emily C.; Harkness, John H.

Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders. Cambridge University Press, 2014. p. 330-349.

Research output: Chapter in Book/Report/Conference proceedingChapter

Phillips, T, Eastwood, EC & Harkness, JH 2014, Drug abuse: Amphetamines. in Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders. Cambridge University Press, pp. 330-349. https://doi.org/10.1007/CBO9781107360556
Phillips T, Eastwood EC, Harkness JH. Drug abuse: Amphetamines. In Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders. Cambridge University Press. 2014. p. 330-349 https://doi.org/10.1007/CBO9781107360556
Phillips, Tamara ; Eastwood, Emily C. ; Harkness, John H. / Drug abuse : Amphetamines. Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders. Cambridge University Press, 2014. pp. 330-349
@inbook{7c98b9ffbefc43f1840a3d445ae5dd77,
title = "Drug abuse: Amphetamines",
abstract = "Amphetamine and amphetamine analogues, such as methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA), have been used for many reasons. Amphetamine has well-known stimulant properties and was once commonly prescribed for treatment of depression and obesity (Anglin et al., 2000). Amphetamine-like drugs and psychostimulants such as methylphenidate and modainil are currently sometimes prescribed for treatment of attention-deicit hyperactivity disorder (ADHD) and narcolepsy, and may be “self-prescribed” as cognitive enhancers (Fredriksen et al., 2013; Hirai and Nishino, 2011; Steiner and Van Waes, 2013). However, amphetamines have profound abuse potential and a high risk for neurotoxicity with chronic use and dependency. More signiicant problems with addiction tomethamphetamine are currently seen and the clinical pharmacology has been nicely reviewed (Cruickshank and Dyer, 2009). However, a recent paper compared the efects of intranasal d-amphetamine and methamphetamine on mood, performance, and physiological efects in humans and concluded that the drugs have similar dose-related proiles of efects and may therefore have equivalent abuse potential (Kirkpatrick et al., 2012a).",
author = "Tamara Phillips and Eastwood, {Emily C.} and Harkness, {John H.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/CBO9781107360556",
language = "English (US)",
isbn = "9781107360556",
pages = "330--349",
booktitle = "Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Drug abuse

T2 - Amphetamines

AU - Phillips, Tamara

AU - Eastwood, Emily C.

AU - Harkness, John H.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Amphetamine and amphetamine analogues, such as methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA), have been used for many reasons. Amphetamine has well-known stimulant properties and was once commonly prescribed for treatment of depression and obesity (Anglin et al., 2000). Amphetamine-like drugs and psychostimulants such as methylphenidate and modainil are currently sometimes prescribed for treatment of attention-deicit hyperactivity disorder (ADHD) and narcolepsy, and may be “self-prescribed” as cognitive enhancers (Fredriksen et al., 2013; Hirai and Nishino, 2011; Steiner and Van Waes, 2013). However, amphetamines have profound abuse potential and a high risk for neurotoxicity with chronic use and dependency. More signiicant problems with addiction tomethamphetamine are currently seen and the clinical pharmacology has been nicely reviewed (Cruickshank and Dyer, 2009). However, a recent paper compared the efects of intranasal d-amphetamine and methamphetamine on mood, performance, and physiological efects in humans and concluded that the drugs have similar dose-related proiles of efects and may therefore have equivalent abuse potential (Kirkpatrick et al., 2012a).

AB - Amphetamine and amphetamine analogues, such as methamphetamine and 3, 4-methylenedioxymethamphetamine (MDMA), have been used for many reasons. Amphetamine has well-known stimulant properties and was once commonly prescribed for treatment of depression and obesity (Anglin et al., 2000). Amphetamine-like drugs and psychostimulants such as methylphenidate and modainil are currently sometimes prescribed for treatment of attention-deicit hyperactivity disorder (ADHD) and narcolepsy, and may be “self-prescribed” as cognitive enhancers (Fredriksen et al., 2013; Hirai and Nishino, 2011; Steiner and Van Waes, 2013). However, amphetamines have profound abuse potential and a high risk for neurotoxicity with chronic use and dependency. More signiicant problems with addiction tomethamphetamine are currently seen and the clinical pharmacology has been nicely reviewed (Cruickshank and Dyer, 2009). However, a recent paper compared the efects of intranasal d-amphetamine and methamphetamine on mood, performance, and physiological efects in humans and concluded that the drugs have similar dose-related proiles of efects and may therefore have equivalent abuse potential (Kirkpatrick et al., 2012a).

UR - http://www.scopus.com/inward/record.url?scp=84953281270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953281270&partnerID=8YFLogxK

U2 - 10.1007/CBO9781107360556

DO - 10.1007/CBO9781107360556

M3 - Chapter

SN - 9781107360556

SN - 9781107044456

SP - 330

EP - 349

BT - Behavioral Genetics of the Mouse Volume II: Genetic Mouse Models of Neurobehavioral Disorders

PB - Cambridge University Press

ER -